HEALTHSTREAM INC (HSTM) Fundamental Analysis & Valuation
NASDAQ:HSTM • US42222N1037
Current stock price
20.45 USD
+0.05 (+0.25%)
At close:
20.45 USD
0 (0%)
After Hours:
This HSTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HSTM Profitability Analysis
1.1 Basic Checks
- In the past year HSTM was profitable.
- HSTM had a positive operating cash flow in the past year.
- HSTM had positive earnings in each of the past 5 years.
- HSTM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of HSTM (3.52%) is better than 82.86% of its industry peers.
- The Return On Equity of HSTM (5.18%) is better than 82.86% of its industry peers.
- HSTM has a better Return On Invested Capital (4.08%) than 77.14% of its industry peers.
- HSTM had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 7.41%.
- The 3 year average ROIC (3.91%) for HSTM is below the current ROIC(4.08%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 5.18% | ||
| ROIC | 4.08% |
ROA(3y)3.49%
ROA(5y)2.82%
ROE(3y)5.07%
ROE(5y)4.11%
ROIC(3y)3.91%
ROIC(5y)3.2%
1.3 Margins
- With an excellent Profit Margin value of 6.03%, HSTM belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
- HSTM's Profit Margin has been stable in the last couple of years.
- Looking at the Operating Margin, with a value of 6.65%, HSTM is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
- HSTM's Operating Margin has been stable in the last couple of years.
- Looking at the Gross Margin, with a value of 64.74%, HSTM is in line with its industry, outperforming 57.14% of the companies in the same industry.
- In the last couple of years the Gross Margin of HSTM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.65% | ||
| PM (TTM) | 6.03% | ||
| GM | 64.74% |
OM growth 3Y12.71%
OM growth 5Y0.62%
PM growth 3Y9.98%
PM growth 5Y0.93%
GM growth 3Y-0.57%
GM growth 5Y0.38%
2. HSTM Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HSTM is destroying value.
- HSTM has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, HSTM has less shares outstanding
- HSTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 3.20 indicates that HSTM is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.20, HSTM is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
- There is no outstanding debt for HSTM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.2 |
ROIC/WACC0.4
WACC10.1%
2.3 Liquidity
- A Current Ratio of 0.96 indicates that HSTM may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.96, HSTM is doing worse than 82.86% of the companies in the same industry.
- A Quick Ratio of 0.96 indicates that HSTM may have some problems paying its short term obligations.
- With a Quick ratio value of 0.96, HSTM is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.96 |
3. HSTM Growth Analysis
3.1 Past
- HSTM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.06%.
- The Earnings Per Share has been growing by 16.23% on average over the past years. This is quite good.
- Looking at the last year, HSTM shows a small growth in Revenue. The Revenue has grown by 4.26% in the last year.
- Measured over the past years, HSTM shows a small growth in Revenue. The Revenue has been growing by 4.43% on average per year.
EPS 1Y (TTM)6.06%
EPS 3Y21.53%
EPS 5Y16.23%
EPS Q2Q%12.5%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y4.45%
Revenue growth 5Y4.43%
Sales Q2Q%7.37%
3.2 Future
- Based on estimates for the next years, HSTM will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.94% on average per year.
- Based on estimates for the next years, HSTM will show a small growth in Revenue. The Revenue will grow by 4.81% on average per year.
EPS Next Y9.29%
EPS Next 2Y11.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.55%
Revenue Next 2Y6.82%
Revenue Next 3Y4.19%
Revenue Next 5Y4.81%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. HSTM Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 29.21 indicates a quite expensive valuation of HSTM.
- 68.57% of the companies in the same industry are more expensive than HSTM, based on the Price/Earnings ratio.
- HSTM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.60.
- A Price/Forward Earnings ratio of 26.73 indicates a quite expensive valuation of HSTM.
- 62.86% of the companies in the same industry are more expensive than HSTM, based on the Price/Forward Earnings ratio.
- HSTM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.21 | ||
| Fwd PE | 26.73 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HSTM is valued a bit cheaper than 80.00% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSTM indicates a somewhat cheap valuation: HSTM is cheaper than 68.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.27 | ||
| EV/EBITDA | 8.2 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSTM does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of HSTM may justify a higher PE ratio.
PEG (NY)3.15
PEG (5Y)1.8
EPS Next 2Y11.94%
EPS Next 3YN/A
5. HSTM Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.60%, HSTM is not a good candidate for dividend investing.
- HSTM's Dividend Yield is rather good when compared to the industry average which is at 0.59. HSTM pays more dividend than 91.43% of the companies in the same industry.
- With a Dividend Yield of 0.60, HSTM pays less dividend than the S&P500 average, which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
5.2 History
- The dividend of HSTM is nicely growing with an annual growth rate of 148.95%!
- HSTM has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)148.95%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- 20.33% of the earnings are spent on dividend by HSTM. This is a low number and sustainable payout ratio.
- The dividend of HSTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP20.33%
EPS Next 2Y11.94%
EPS Next 3YN/A
HSTM Fundamentals: All Metrics, Ratios and Statistics
20.45
+0.05 (+0.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners73.32%
Inst Owner Change-1.94%
Ins Owners16.99%
Ins Owner Change-22.28%
Market Cap600.41M
Revenue(TTM)304.06M
Net Income(TTM)18.34M
Analysts78.18
Price Target21.42 (4.74%)
Short Float %4.57%
Short Ratio3.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
Yearly Dividend0.12
Dividend Growth(5Y)148.95%
DP20.33%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-09 2026-03-09 (0.035)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.92%
Min EPS beat(2)11.41%
Max EPS beat(2)60.43%
EPS beat(4)3
Avg EPS beat(4)18.24%
Min EPS beat(4)-12.02%
Max EPS beat(4)60.43%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)29.71%
EPS beat(16)15
Avg EPS beat(16)53.52%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)2.56%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-3.85%
Max Revenue beat(4)2.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.5%
Revenue beat(12)1
Avg Revenue beat(12)-1.71%
Revenue beat(16)1
Avg Revenue beat(16)-1.92%
PT rev (1m)-35.38%
PT rev (3m)-38.24%
EPS NQ rev (1m)-1.52%
EPS NQ rev (3m)1.56%
EPS NY rev (1m)-1.57%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)3.49%
Revenue NQ rev (3m)3.49%
Revenue NY rev (1m)3.49%
Revenue NY rev (3m)3.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.21 | ||
| Fwd PE | 26.73 | ||
| P/S | 1.97 | ||
| P/FCF | 19.27 | ||
| P/OCF | 9.48 | ||
| P/B | 1.7 | ||
| P/tB | 23.1 | ||
| EV/EBITDA | 8.2 |
EPS(TTM)0.7
EY3.42%
EPS(NY)0.77
Fwd EY3.74%
FCF(TTM)1.06
FCFY5.19%
OCF(TTM)2.16
OCFY10.55%
SpS10.36
BVpS12.06
TBVpS0.89
PEG (NY)3.15
PEG (5Y)1.8
Graham Number13.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 5.18% | ||
| ROCE | 5.11% | ||
| ROIC | 4.08% | ||
| ROICexc | 4.76% | ||
| ROICexgc | 144.29% | ||
| OM | 6.65% | ||
| PM (TTM) | 6.03% | ||
| GM | 64.74% | ||
| FCFM | 10.25% |
ROA(3y)3.49%
ROA(5y)2.82%
ROE(3y)5.07%
ROE(5y)4.11%
ROIC(3y)3.91%
ROIC(5y)3.2%
ROICexc(3y)4.86%
ROICexc(5y)3.91%
ROICexgc(3y)162.5%
ROICexgc(5y)114.53%
ROCE(3y)4.9%
ROCE(5y)4.01%
ROICexgc growth 3Y31.22%
ROICexgc growth 5Y26.84%
ROICexc growth 3Y16.25%
ROICexc growth 5Y4.77%
OM growth 3Y12.71%
OM growth 5Y0.62%
PM growth 3Y9.98%
PM growth 5Y0.93%
GM growth 3Y-0.57%
GM growth 5Y0.38%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 73.98% | ||
| Cap/Sales | 10.58% | ||
| Interest Coverage | 200.35 | ||
| Cash Conversion | 99.38% | ||
| Profit Quality | 169.87% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 3.2 |
F-Score6
WACC10.1%
ROIC/WACC0.4
Cap/Depr(3y)70.13%
Cap/Depr(5y)69.08%
Cap/Sales(3y)10.09%
Cap/Sales(5y)9.91%
Profit Quality(3y)184.6%
Profit Quality(5y)212.64%
High Growth Momentum
Growth
EPS 1Y (TTM)6.06%
EPS 3Y21.53%
EPS 5Y16.23%
EPS Q2Q%12.5%
EPS Next Y9.29%
EPS Next 2Y11.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.26%
Revenue growth 3Y4.45%
Revenue growth 5Y4.43%
Sales Q2Q%7.37%
Revenue Next Year8.55%
Revenue Next 2Y6.82%
Revenue Next 3Y4.19%
Revenue Next 5Y4.81%
EBIT growth 1Y-4.95%
EBIT growth 3Y17.73%
EBIT growth 5Y5.07%
EBIT Next Year266.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.55%
FCF growth 3Y6.09%
FCF growth 5Y12.79%
OCF growth 1Y9.81%
OCF growth 3Y7.35%
OCF growth 5Y12.04%
HEALTHSTREAM INC / HSTM Fundamental Analysis FAQ
What is the fundamental rating for HSTM stock?
ChartMill assigns a fundamental rating of 5 / 10 to HSTM.
What is the valuation status for HSTM stock?
ChartMill assigns a valuation rating of 4 / 10 to HEALTHSTREAM INC (HSTM). This can be considered as Fairly Valued.
How profitable is HEALTHSTREAM INC (HSTM) stock?
HEALTHSTREAM INC (HSTM) has a profitability rating of 7 / 10.
What is the valuation of HEALTHSTREAM INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHSTREAM INC (HSTM) is 29.21 and the Price/Book (PB) ratio is 1.7.
Can you provide the dividend sustainability for HSTM stock?
The dividend rating of HEALTHSTREAM INC (HSTM) is 4 / 10 and the dividend payout ratio is 20.33%.